Docetaxel topotecan. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Cell Line, Tumor

Organisms1

Diseases21

Neutropenia Lung Neoplasms Ovarian Neoplasms Breast Neoplasms Neoplasms Neoplasm Recurrence, Local Carcinoma, Non-Small-Cell Lung Asthenia Prostatic Neoplasms Carcinoma, Small Cell Leukopenia Thrombocytopenia Neoplasm Metastasis Peritoneal Neoplasms Hematologic Diseases Retinal Neoplasms Rhabdomyosarcoma Adenocarcinoma Nausea Small Cell Lung Carcinoma Vomiting

Chemicals and Drugs24

Topotecan Taxoids Topoisomerase I Inhibitors Antineoplastic Agents, Phytogenic Antineoplastic Agents Paclitaxel Camptothecin Cisplatin DNA Topoisomerases, Type I Deoxycytidine Topoisomerase Inhibitors Mitoxantrone Estramustine Doxorubicin Carboplatin Fluorouracil Epirubicin Granulocyte Colony-Stimulating Factor Vinblastine ATP-Binding Cassette Transporters Acridines Oxonic Acid Cyclophosphamide Antibodies, Monoclonal, Humanized

Analytical, Diagnostic and Therapeutic Techniques and Equipment20

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Infusions, Intravenous Maximum Tolerated Dose Treatment Outcome Area Under Curve Administration, Oral Survival Analysis Xenograft Model Antitumor Assays Disease-Free Survival Survival Rate Drug Screening Assays, Antitumor Clinical Trials, Phase II as Topic Neoadjuvant Therapy Neoplasm Staging Administration, Metronomic Metabolic Clearance Rate Combined Modality Therapy Salvage Therapy Clinical Trials, Phase I as Topic

Phenomena and Processes6

Maximum Tolerated Dose Drug Resistance, Neoplasm Dose-Response Relationship, Drug Area Under Curve Drug Synergism Metabolic Clearance Rate

Information Science1

Health Care7

Treatment Outcome Area Under Curve Survival Analysis Disease-Free Survival Survival Rate Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Topotecan Taxoids Topoisomerase I Inhibitors Antineoplastic Agents, Phytogenic Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Paclitaxel Drug Administration Schedule Camptothecin Infusions, Intravenous Neutropenia Lung Neoplasms Cisplatin Maximum Tolerated Dose Ovarian Neoplasms Treatment Outcome Drug Resistance, Neoplasm DNA Topoisomerases, Type I Dose-Response Relationship, Drug Deoxycytidine Breast Neoplasms Area Under Curve Topoisomerase Inhibitors Neoplasms Mitoxantrone Neoplasm Recurrence, Local Administration, Oral Carcinoma, Non-Small-Cell Lung Estramustine Asthenia Prostatic Neoplasms Survival Analysis Carcinoma, Small Cell Leukopenia Doxorubicin Cell Line, Tumor Carboplatin Xenograft Model Antitumor Assays Disease-Free Survival Thrombocytopenia Drug Synergism Neoplasm Metastasis Survival Rate Drug Screening Assays, Antitumor Fluorouracil Epirubicin Peritoneal Neoplasms Granulocyte Colony-Stimulating Factor Vinblastine Hematologic Diseases ATP-Binding Cassette Transporters Clinical Trials, Phase II as Topic Retinal Neoplasms Acridines Oxonic Acid Rhabdomyosarcoma Neoadjuvant Therapy Neoplasm Staging Cyclophosphamide Administration, Metronomic Adenocarcinoma Mice, Nude Nausea Small Cell Lung Carcinoma Metabolic Clearance Rate Vomiting Combined Modality Therapy Antibodies, Monoclonal, Humanized Salvage Therapy Clinical Trials, Phase I as Topic

No FAQ available that match "docetaxel topotecan"